FDA Drug Recalls

Recalls / Class II

Class IID-0345-2022

Product

Perrigo Fexofenadine Hydrochloride tablets, 24HR, 180mg Antihistamine, 100 count bottle, Made in the Czech Republic, Distributed by Perrigo Allergan, MI 49010 NDC 45802-571-78 UPC 3 45802 571 78 6

Affected lot / code info
Lot 0FR0563, Exp 02/28/22; 0GR0530, Exp 03/31/22; 0KR0434, 0KR0435, 0LR0366, 0LR0367, 0LR0368, Exp 06/30/22.

Why it was recalled

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Recalling firm

Firm
Perrigo Company PLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
89,664 containers
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2021-07-27
FDA classified
2022-01-05
Posted by FDA
2022-01-12
Terminated
2022-11-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0345-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls